[Disease modifying anti-rheumatic drugs (DMARDs): an overview]

Nihon Rinsho. 2005 Jan:63 Suppl 1:489-92.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antirheumatic Agents* / administration & dosage
  • Antirheumatic Agents* / adverse effects
  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Benzopyrans
  • Cysteine / analogs & derivatives*
  • Evidence-Based Medicine
  • Gold Sodium Thiomalate
  • Humans
  • Isoxazoles
  • Leflunomide
  • Meta-Analysis as Topic
  • Methotrexate
  • Randomized Controlled Trials as Topic
  • Sulfasalazine
  • Sulfonamides

Substances

  • Antirheumatic Agents
  • Benzopyrans
  • Isoxazoles
  • Sulfonamides
  • Gold Sodium Thiomalate
  • T 614
  • Sulfasalazine
  • Leflunomide
  • Cysteine
  • bucillamine
  • Methotrexate